You have 9 free searches left this month | for more free features.

remdesivir

Showing 26 - 50 of 60

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Covid19, Pneumonia Trial in Bani Suwayf (Remdesivir, Hydroxychloroquine, Tocilizumab)

Recruiting
  • Covid19
  • Pneumonia
  • Remdesivir
  • +4 more
  • Banī Suwayf, Egypt
    Beni-suef University
Mar 15, 2021

Covid19 Trial in Kingston (Remdesivir, Acalabrutinib, Interferon beta-1a)

Not yet recruiting
  • Covid19
  • Remdesivir
  • +3 more
  • Kingston, Jamaica
    Univeristy of the West Indies
May 10, 2021

Covid19 Trial in Italy (Baricitinib Oral Tablet [Olumiant], Remdesivir, Dexamethasone)

Not yet recruiting
  • Covid19
  • Baricitinib Oral Tablet [Olumiant]
  • +2 more
  • Ancona, Italy
  • +20 more
Apr 3, 2021

COVID-19 Trial in United States (Merimepodib, Matching Placebo, Remdesivir)

Terminated
  • COVID-19
  • Phoenix, Arizona
  • +9 more
Dec 4, 2020

COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

Terminated
  • COVID-19
  • Remdesivir
  • +2 more
  • Birmingham, Alabama
  • +62 more
Jun 1, 2022

Covid19, Covid-19 ARDS Trial in Dinajpur (Remdesivir, Baricitinib, Tocilizumab)

Recruiting
  • Covid19
  • Covid-19 ARDS
  • Remdesivir
  • +2 more
  • Dinajpur, Bangladesh
    M. Abdur Rahim Medical College Hospital
Dec 31, 2020

COVID-19, Remdesivir, SARS-CoV-2 Trial in Beijing (Remdesivir, Remdesivir )

Terminated
  • COVID-19
  • +2 more
  • Remdesivir
  • Remdesivir placebo
  • Beijing, Beijing, China
    Bin Cao
Apr 13, 2020

COVID-19 Trial in Russian Federation (Favipiravir, Remdesivir)

Completed
  • COVID-19
  • Ivanovo, Russian Federation
  • +5 more
Jan 7, 2022

COVID-19, SARS-CoV-2 Trial in Wuhan (Remdesivir, Remdesivir )

Suspended
  • COVID-19
  • SARS-CoV-2
  • Remdesivir
  • Remdesivir placebo
  • Wuhan, Hubei, China
    Jin Yin-tan hospital
Apr 13, 2020

Covid19 Trial in Kathmandu, Pokhara (Favipiravir, Placebo, Remdesivir)

Recruiting
  • Covid19
  • Kathmandu, Bagmati, Nepal
  • +1 more
Jan 3, 2021

Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in United States

Terminated
  • Coronavirus Disease 2019 (COVID-19)
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • anti-CD14
  • +2 more
  • Torrance, California
  • +13 more
Mar 24, 2022

CoVid 19 Positive Trial in Los Angeles (Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine,

Completed
  • CoVid 19 Positive
  • Hydroxychloroquine, Azithromycin
  • +10 more
  • Los Angeles, California
    FHHI-OI-Camelot; QME
Nov 10, 2020

COVID-19 Trial in United States (other, drug, biological)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +31 more
Nov 23, 2022

COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)

Unknown status
  • COVID-19
  • Chloroquine or Hydroxychloroquine
  • +11 more
  • Innsbruck, Tirol, Austria
  • +8 more
Feb 25, 2021

Covid19 Trial in Philippines (Remdesivir, Hydroxychloroquine, Lopinavir / Ritonavir)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Baguio City, Benguet, Philippines
  • +24 more
Feb 27, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)

Completed
  • COVID
  • +3 more
  • Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
  • +2 more
  • Colorado Springs, Colorado
  • +38 more
Mar 31, 2022

Covid19, Cytokine Release Syndrome, Critical Illness Trial in Rawalpindi (procedure, biological, drug)

Completed
  • Covid19
  • +3 more
  • Therapeutic Plasma exchange
  • +4 more
  • Rawalpindi, Punjab, Pakistan
    Pak Emirates Military Hospital
Jul 28, 2020

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

SARS-CoV Infection, COVID 19, Acute Respiratory Distress Syndrome ARDS Trial in Oslo (Hydroxychloroquine, Remdesivir, (Standard

Unknown status
  • SARS-CoV Infection
  • +2 more
  • Oslo, Norway
    Andreas Barratt-Due
Apr 10, 2020

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +38 more
Jul 21, 2022

SARS-CoV-2 Infection, COVID-19, Moderate and Severe COVID-19 Trial in Germany (Standard of Care (SoC), Remdesivir)

Active, not recruiting
  • SARS-CoV-2 Infection
  • +2 more
  • Standard of Care (SoC)
  • Remdesivir
  • Bremen, Germany
  • +3 more
Oct 2, 2020

Corona Virus Infection Trial in Worldwide (Remdesivir, Lopinavir/ritonavir, Interferon Beta-1A)

Active, not recruiting
  • Corona Virus Infection
  • Remdesivir
  • +6 more
  • Innsbruck, Austria
  • +61 more
Jul 1, 2022